feed,title,long_url,short_url
Benzinga,AbbVie's Migraine Treatment Drug Touts Encouraging Data In Preventive Treatment Setting,https://benzinga.com/general/biotech/22/03/26083655/abbvies-migraine-treatment-drug-touts-encouraging-data-in-preventive-treatment-setting,https://bit.ly/3KxYLCN
Benzinga,Lazydays Clocks 64% Top-Line Growth In Q4,https://benzinga.com/news/earnings/22/03/26084474/lazydays-clocks-64-top-line-growth-in-q4,https://bit.ly/35NOILd
Benzinga,"Bioventus Posts Q4 Profit Ahead Of Consensus, Forecasts FY22 Sales Jump Of ~30%",https://benzinga.com/news/earnings/22/03/26085132/bioventus-posts-q4-profit-ahead-of-consensus-forecasts-fy22-sales-jump-of-30,https://bit.ly/3J691C0
